Uganda Grapples wiht Deadly Sudan Virus Outbreak
Table of Contents
KAMPALA, Uganda — As of Feb. 20, 2025, uganda is battling a concerning outbreak of sudan virus disease (SVD), a severe illness related to Ebola. nine confirmed cases, including one death, have been reported since the outbreak was declared on jan. 30, 2025. The situation underscores the urgent need for swift and effective public health intervention, given the virus’s high fatality rate, ranging from 41% to 70% in past outbreaks.the World Health Association (WHO) has stepped in to provide crucial support.
The first case, a health worker, experienced symptom onset on Jan. 19, 2025. The case initially self-medicated with antimalarials and sought care in different health facilities located in Wakiso, kampala and Mbale districts, and also a customary healer in Mbale, before being referred to Mulago referral hospital, where he died on 29 January 2025,
according to health officials. His death prompted a rapid response, including a detailed case investigation and extensive contact tracing.
Eight additional cases, primarily family members and healthcare workers who had contact with the initial patient, were subsequently confirmed.These individuals, ranging in age from 1.5 to 49 years, with a mean age of 27, and 56% male, presented symptoms between Jan. 29 and Feb. 6. All were detected at early onset of their disease by contact tracing team while in quarantine,
officials reported. They received treatment, including Remdesivir under the Monitored emergency use of unregistered and experimental interventions (MEURI) protocol, at Mulago national Referral Hospital (seven cases) and Mbale Regional Referral Hospital (one case). All eight were discharged on Feb.18, 2025, after two negative tests 72 hours apart.
The outbreak has spread across four districts: jinja, Kampala, Mbale, and Wakiso.As of Feb. 20, 299 contacts have been identified, with 58 still under monitoring in designated quarantine facilities.The Ministry of Health (MoH) has activated its national and subnational coordination structures, including the incident Management team and Rapid Response Teams. A National Response Plan (Febuary-April 2025) has been developed, building on lessons from previous outbreaks.
The MoH, with support from the WHO and partners, has implemented several key measures: strengthened laboratory capacity, including a mobile laboratory in Mbale; established a hotline for suspected cases; and conducts exit screening at Uganda’s 13 high-volume points of entry. Three designated isolation and treatment units are operational in Jinja, Kampala, and mbale.A safe and dignified burial was provided for the first case.Moreover, a full genome sequencing
was performed on the first case’s sample, indicating a likely spillover event.
The WHO has released US$3.4 million from its Contingency Fund for Emergency response. The “TOKEMEZA SVD” vaccine trial was launched on Feb.3, 2025. A WHO team of 47 experts is supporting the response across various pillars, including coordination, surveillance, laboratory work, logistics, infection prevention and control, risk interaction, community engagement, and case management.The WHO also emphasizes the importance of risk communication and community engagement to counter misinformation and promote early reporting.
This is Uganda’s sixth SVD outbreak; the most recent prior outbreak, in September 2022, involved 164 cases and 55 deaths. While Uganda has experience managing such outbreaks, the high case fatality rate of SVD and the absence of licensed vaccines and therapeutics highlight the meaningful public health risk. The WHO advises against travel or trade restrictions to Uganda based on current information.
Sudan virus disease is a severe disease, belonging to the same family as Ebola virus disease. it is indeed caused by Sudan virus (SUDV) and can result in high case fatality. It is typically characterized by acute onset of fever with non-specific symptoms/signs (e.g., abdominal pain, anorexia, fatigue, malaise, myalgia, sore throat) usually followed several days later by nausea, vomiting, diarrhoea, and occasionally a variable rash. Hiccups may occur. Severe illness may include haemorrhagic manifestations (e.g., bleeding from puncture sites, ecchymoses, petechiae, visceral effusions), encephalopathy, shock/hypotension, multi-organ failure, spontaneous abortion in infected pregnant women. Individuals who recover may experience prolonged sequelae (e.g., arthralgia, neurocognitive dysfunction, uveitis sometimes followed by cataract formation), and clinical and subclinical persistent infection may occur in immune-privileged compartments (e.g., CNS, eyes, testes). Person-to-person transmission occurs by direct contact with blood,other bodily fluids,organs,or contaminated surfaces and materials with risk beginning at the onset of clinical signs and increasing with disease severity. Family members, healthcare providers, and participants in burial ceremonies with direct contact with the deceased are at particular risk. The incubation period ranges from 2 to 21 days, but typically is 7–11 days.
Expert Insights: Tackling Uganda’s Deadly Sudan Virus Outbreak
The Silent Threat Lurking in Uganda’s Hearts
Editor: The recent outbreak of Sudan virus Disease (SVD) in Uganda has brought this underreported yet deadly pathogen back into the spotlight. What makes SVD such a notable public health concern, especially in this fifth outbreak uganda has faced?
Expert: Sudan virus Disease is a severe and frequently enough fatal illness, with grave implications for public health. It belongs to the same virus family as Ebola, causing high morbidity with a fatality rate that can soar between 41% and 70%. The primary mode of transmission—through direct contact with bodily fluids of infected individuals—poses substantial risks, particularly in settings like hospitals and family homes where exposure is more likely. moreover, while Uganda has a history of confronting such outbreaks, this threat remains persistent and unpredictable, highlighting the urgency for robust preparedness and response measures globally.
Unraveling a complex and Fatal Outbreak
Editor: Considering Sudan Virus’s high fatality rates, how effective have Uganda’s measures been in controlling the spread so far?
Expert: uganda’s response framework combines immediate containment efforts with strategic, long-term solutions. The government, supported by the World Health Association, has activated critical mechanisms including the establishment of isolation and treatment units, enhanced laboratory capacities, and a thorough national Response plan. During previous outbreaks, Uganda exemplified effective disease control, which remains vital in current efforts. Rapid response teams and contact tracing have been pivotal in averting broader community transmission, exemplified by the successful quarantine and treatment of eight previously unreported cases. deployment of full genome sequencing in this outbreak also illustrates Uganda’s commitment to understanding and managing the outbreak at a molecular level, possibly identifying pathways for better interventions and containment.
Lessons Learned and Long-Term Perspectives
Editor: Looking at the history of SVD outbreaks, what lessons has Uganda learned, and how can they be applied to future outbreaks?
Expert: Ancient data from past outbreaks provide valuable insights into effective control and prevention strategies. For instance, the September 2022 outbreak involved 164 cases and underscored the importance of early detection and rapid isolation of patients. Uganda’s experience emphasizes that community engagement and misinformation management are as critical as clinical interventions.Centralizing efforts by developing robust public health frameworks that incorporate community education about transmission routes and symptom onset can significantly mitigate risks.Going forward, sustained international collaboration and investment in research to develop licensed vaccines will be essential to transforming response strategies from reactive to proactive.
Community Resilience and Public Health Preparedness
Editor: What role do you see for community members and local health facilities in managing and preventing future outbreaks?
Expert: Community members are frontline contributors to outbreak management, tasked with recognizing symptoms early and seeking appropriate medical care rather than relying on unverified treatments.Local health facilities must enhance infection control protocols and ensure that healthcare workers are well-trained in using personal protective equipment. Continued education about SVD is crucial in reducing stigma and ensuring cooperation with public health directives. Encouraging community members to participate in health monitoring can facilitate early case detection, which, when combined with stringent contact tracing, plays a pivotal role in curbing transmission.
Looking Toward a Secure future
Editor: with the current initiatives and vaccine trials underway, what is the horizon for a solution to SVD?
Expert: The recent launch of the “TOKEMEZA SVD” vaccine trial marks a promising step towards developing effective prophylactic measures against Sudan Virus. While these initiatives are promising, success will depend on comprehensive clinical trials and legislative support for vaccine deployment. Continued funding and research are crucial to substantiate early results and fast-track vaccines for approval. Furthermore, building resilience into the public health infrastructure, such as maintaining adequate stockpiles of essential medical supplies and fostering partnerships with international health organizations, can ensure readiness for future outbreaks.
Engage with Us: Have you or someone you know been affected by the Sudan Virus Outbreak? Share your experiences and thoughts on our actions to combat viral outbreaks in the comments section below, or join the conversation on social media. Your insights can contribute to a global effort in understanding and managing infectious diseases.